Skip to main content
. 2017 Feb 23;15(2):e04694. doi: 10.2903/j.efsa.2017.4694

Figure 14.

Figure 14

Trends in resistance to ampicillin, ciprofloxacin/pefloxacin/nalidixic acid, cefotaxime and tetracycline in monophasic Salmonella Typhimurium 1,4,[5],12:i:‐ from humans in reporting countries, 2013–2015

  • A statistically significant increasing trend over 3 years, as tested by logistic regression (p ≤ 0.05), was observed for ampicillin in Denmark (↑). Statistically significant decreasing trends over 3 years were observed for ampicillin, cefotaxime and tetracycline in Spain (↓). Only countries testing at least 10 isolates per year were included in the analysis.